Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Opravil

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1997
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study GroupN Stalder, P Sudre, M Olmari, et al.
The American Journal of Pathology|June 15, 2000
Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infectionH Kuster, M Opravil, P Ott, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
AIDS (London, England)|March 15, 2000
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyS Yerly, L Kaiser, T V Perneger, et al.
Clinical and Experimental Immunology|August 24, 2004
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesisM Hersberger, S Bonhoeffer, S K Rampini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virusM Opravil, M Pechère, A Lazzarin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Infectious complications in 100 consecutive heart transplant recipientsM Waser, M Maggiorini, A Lüthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patientsM Opravil, B Hirschel, A Lazzarin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infectionL R Bisset, R W Cone, M Fischer, et al.
Deutsche Medizinische Wochenschrift (1946)|October 26, 1990
[Pneumocystis carinii pneumonia in HIV infection: better prognosis because of early diagnosis]R Weber, M Opravil, K Bloch, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1997
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study GroupN Stalder, P Sudre, M Olmari, et al.
The American Journal of Pathology|June 15, 2000
Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infectionH Kuster, M Opravil, P Ott, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
AIDS (London, England)|March 15, 2000
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort StudyS Yerly, L Kaiser, T V Perneger, et al.
Clinical and Experimental Immunology|August 24, 2004
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesisM Hersberger, S Bonhoeffer, S K Rampini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virusM Opravil, M Pechère, A Lazzarin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Infectious complications in 100 consecutive heart transplant recipientsM Waser, M Maggiorini, A Lüthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patientsM Opravil, B Hirschel, A Lazzarin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infectionL R Bisset, R W Cone, M Fischer, et al.
Deutsche Medizinische Wochenschrift (1946)|October 26, 1990
[Pneumocystis carinii pneumonia in HIV infection: better prognosis because of early diagnosis]R Weber, M Opravil, K Bloch, et al.
Pageof 12